(Q37831953)

24 August 2017

1 reference

title

MALT lymphoma: many roads lead to nuclear factor-κb activation (English)

1 reference

24 August 2017

1 reference

1 reference

Ming-Qing Du

1

1 reference

24 August 2017

publication date

1 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

58

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

26-38

1 reference

The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Post-translational modifications regulate distinct functions of CARMA1 and BCL10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The role of ubiquitin in NF-kappaB regulatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Deubiquitylation and regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

New insights into NF-kappaB regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A20: central gatekeeper in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

MALT lymphoma : recent advances in aetiology and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

mE10, a novel caspase recruitment domain-containing proapoptotic molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 can promote survival of antigen-stimulated B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The proteolytic activity of the paracaspase MALT1 is key in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Foxp1 is an essential transcriptional regulator of B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Frequent inactivation of A20 in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Two independent alleles at 6q23 associated with risk of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Malignancies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Maintenance of serological memory by polyclonal activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Proteasome inhibition as a novel therapeutic target in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

A loss-of-function RNA interference screen for molecular targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

MALT lymphoma: from morphology to molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03699.X

10.1111/J.1365-2559.2010.03699.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference